Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid vs Pregabalin Plus Naproxen Sodium in Oral Cancer Pain
NCT07606638Enrolling by invitation
- Sponsor
- Mayo Clinic
- Start
- Feb 2026
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of pregabalin and Aprol in cancer pain (2 arms), sponsored by Mayo Clinic. Primary endpoint: Mean Change in Visual Analog Scale Pain Score at 7 days. Started Feb 2026; status: enrolling by invitation.
02
Drugs
pregabalinAprol
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT07606638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07606638.